Navigation Links
Acuo Technologies(R) Offers Free Migration Archive License
Date:2/25/2008

ew PACS. This

strategy eliminates the need to delay using the new PACS while trying

to migrate data from the old PACS. The early migration allows quicker

use of the new PACS and shutdown of the old PACS, saving money and

time.

-- PACS replacement risk management. IT projects are not always

successful, but it can be even more painful to change vendors when the

project sours. This difficulty is due to the time and cost of

migration that is required to install the new PACS, and the realization

that it would need to be redone in order to switch to another PACS. By

implementing the low cost Migration Archive, a Hospital is able to

hedge their risk of moving to a new PACS by allowing the rapid transfer

to a new PACS in case the first PACS did not meet their needs.

-- The Migration Archive can be upgraded to a Disaster Recovery Archive

for use not only as a secondary source of the legacy images, but as

DICOM compliant archive for new studies. By retaining both sets of

images, the need to pay for future migrations is eliminated.

-- The Migration Archive can also be the foundation for all "Ologies" as

either a Disaster Recovery Archive or as a primary Vendor Neutral

Archive for Cardiology, Vascular, and all image producing departments.

As with all solutions from Acuo Technologies, the Migration Archive is software which allows the use of servers and storage that is in line with the facilities strategy, not the vendor's limited hardware selection. Acuo will work with you to design the best hardware solution that incorporates IT's existing infrastructure, leverages new technology, and ensures the ability to grow as needed without the standard "rip and replace" schema seen with other PACS vendors.

Acuo Technologies, an image management software company, will be demonstrating DICOM Services Grid soft
'/>"/>

SOURCE Acuo Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Global Med Technologies(R) Extends Its Worldwide Outreach
2. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
3. Global Med Technologies(R), Inc.s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference
4. Global Med Technologies(R) Inc. to Announce Third Quarter Results On October 30th - Conference Call to Follow Release
5. Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA
6. Global Med Technologies(R) to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Global Med Technologies(R), Inc. Adds Wyoming Hospital to Growing Customer Base
8. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
9. At HIMSS 08, RF Technologies(R) Will Host LIVE! Demonstrations of PinPoint(R) Peer-to-Peer Wi-Fi RTLS - a Breakthrough in Location-Aware Solutions
10. Global Med Technologies(R), Inc. Recieves FDA 510(K) Clearance for ElDorado Donor(TM)
11. Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...archers has revealed that the inhalers which asthm... chances of an attack.// Mathematical modeling tec...as to when an asthma attack is likely to take plac...ished the results of the study. Silverman, profess...
...n the NHS to make improvements in the services it ...ared that children who are terminally ill should n...st care. A guidance has been issued by the Depart...vidual needs must be catered to while providing tr...
...singly been paying lesser attention to programs wi...ment to the school, and social development. The So...// of Washington conducted a study of almost 600 ... tendencies like violence, delinquency, and substa...
...bial coating over artificial implants such as hip,...duce the infection rates following surgery. // Thi...t reduction in the health care cost and an improve...nts. Following surgery, the implantable devices a...
Other Medicine News:Health News:Asthma Attacks May Be Triggered By Inhalers 2Health News:Anti-Microbial Coating For Use Over Biomedical Devices Developed 2
(Date:10/10/2008)...tment with Kogenate FS Reduces the,Risk of Joint D...Existing,Joint Damage, BERKELEY, Calif., Oct. 10 ...ay that the U.S. Food and Drug Administration (FDA...) FS Antihemophilic Factor,(Recombinant) to reduce...f,joint damage in patients aged 0-16 years with se...
(Date:10/9/2008)...e need to protect the eyesight of,older people, N...people worldwide who,are blind, 80 percent are ove...oided their blindness if they had been properly di...Release, go to:, http://www.prnewswire.com/mnr/orb... products and equipment, is,partnering with nonpro...
(Date:10/8/2008)...e-USNewswire/ -- The facts are,overwhelming. Every...-Saharan Africa. More than 35,000,000 women, child...ed of AIDS. The Foundation for Hospices,in Sub-Sah...ir families,find compassion and relief from suffer...ing initiative links African hospices and palliati...
(Date:10/8/2008)...ts Expand Testing Using Cellular ... Oct. 8 /- Wild Blueberry antioxidant...ts from a new study,showing Wild Blueberries outpe...e apples, bananas, red grapes and strawberries in ...tivity (CAA) assay. New research,published in the ...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 1ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 3Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call 4896 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 1Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 3Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 4
...un 7, 2007 - Clinical results from a,Phase II stud...dache Society (AHS) annual meeting showed that MK-...ted peptide (CGRP),receptor antagonist, significan...dosing compared to placebo, and the relief was,sus...l tolerated in,the study. Responses specific to ot...
...ndpoints for Both Efficacy and Safety, LEXINGTON, ...evus Pharmaceuticals, Inc. today announced final r...r NEBIDO (testosterone,undecanoate), a long- actin...t for the treatment of male hypogonadism which the...ermany. The data,from the recently completed 48-we...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: